chr1-220635953-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_018650.5(MARK1):āc.1397T>Cā(p.Val466Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000103 in 1,613,694 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018650.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MARK1 | NM_018650.5 | c.1397T>C | p.Val466Ala | missense_variant | 13/18 | ENST00000366917.6 | NP_061120.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MARK1 | ENST00000366917.6 | c.1397T>C | p.Val466Ala | missense_variant | 13/18 | 1 | NM_018650.5 | ENSP00000355884 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151972Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251136Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135718
GnomAD4 exome AF: 0.000111 AC: 162AN: 1461722Hom.: 0 Cov.: 31 AF XY: 0.000110 AC XY: 80AN XY: 727158
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151972Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74238
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 31, 2023 | The c.1397T>C (p.V466A) alteration is located in exon 13 (coding exon 13) of the MARK1 gene. This alteration results from a T to C substitution at nucleotide position 1397, causing the valine (V) at amino acid position 466 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at